Products

What will AGI do for Alloclamide?

This classification denotes an antitussive agent with the molecular formula C16H23ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) H7B263Z7AQ, chemically known as benzamide, 4-chloro-n-(2-(diethylamino)ethyl)-2-(2-propenyloxy)- (9ci) but more generally known as alloclamide, which bears US NIH Compound Identifier 71837. Alloclamide comes in forms base and hydrochloride. European Medicines Agency schedules Alloclamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05335MIG. The term ALLOCLAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 21 No. 12 1967, List 7). ALLOCLAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule alloclamide under HS 29242995 and SITC 51479. As of Q4 2014, ALLOCLAMIDE remains US FDA's Preferred Term for this commodity. Alloclamide bears US NLM identifiers UMLS ID C0051206 and NCI Concept Code C73184. SMILES: CLC1CC(OCC=C)C(C(=O)NCCN(CC)CC)CC1.